MedPath

Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome

Not Applicable
Completed
Conditions
Interpersonal Psychotherapy
Polycystic Ovary Syndrome
Interventions
Behavioral: Interpersonal Psychotherapy
Registration Number
NCT06056453
Lead Sponsor
University of Colorado, Denver
Brief Summary

The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Diagnosed with PCOS duration > 3 months
  • 12-17 years old
  • BMI > 75th percentile
  • CESD > 16
Read More
Exclusion Criteria
  • Weekly or bi-weekly therapy with licensed behavioral health provider
  • Inability to speak, read, or write in English (teen)
  • Major medical conditions
  • HbA1c > 7.0%
  • Hormonal contraception < 3 months
  • Metformin < 3 months
  • Antidepressants/psychotropic medications < 4 weeks
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
IPTInterpersonal PsychotherapyParticipate in IPT 6-week intervention group.
Primary Outcome Measures
NameTimeMethod
Center for Epidemiologic Studies-Depression Scale6-Month Follow-Up Assessment

Depression symptoms will be assessed by the Center for Epidemiologic Studies-Depression Scale. Scores range from 1 to 4. The scoring of positive items is reversed. Possible range of scores is zero to 60, with the higher scores indicating the presence of more symptomatology.

Secondary Outcome Measures
NameTimeMethod
Emotional Eating Scale Adapted for ChildrenBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Disordered eating will be assessed by the Emotional Eating Scale Adapted for Children. The scale has been adapted for children and assesses eating in response to negative affect, such as feeling sad or irritated. The scale ranges from "I have no desire to eat" to "I have a very strong desire to eat" and averages how many days a week the participant eats based on that feeling.

BMIBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Fasting BMI (kg/m2) will be derived from measured height in triplicate by stadiometer and measured fasting weight by calibrated digital scale. BMI z-score and BMI %ile will be computed to determine eligibility (BMI ≥75th percentile).

Insulin ResistanceBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Blood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure fasting insulin. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).

Loss-of-Control Eating Disorder QuestionnaireBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Loss-of-control eating will be assessed via the 19-item Loss-of-Control Eating Disorder Questionnaire (LOC-ED-Q), which shows sound psychometric properties in adolescents using Yes/No.

DysglycemiaBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Blood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure fasting insulin. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).

Reward Based Eating Drive ScaleBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Reward based eating will be assessed by the Reward Based Eating Drive Scale. This is a self-report questionnaire which assesses reward-based eating that shows sound psychometric properties. The total score is summed at the end; a higher total is indicative of reward-based eating.

DyslipidemiaBaseline, 6-Week Follow-Up Assessment, 6-Month Follow-Up Assessment

Blood will be sampled via a venipuncture procedure following a 10-hour overnight fast to measure dyslipidemia. Insulin resistance will be estimated from fasting insulin and glucose with the homeostatic model assessment of insulin resistance (HOMA-IR).

Trial Locations

Locations (1)

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath